Our Portfolio

The easiest path to AI for antibody scientists

EVQLV: verb \ ē-ˈvälv, -ˈvȯlv \ to change or develop – often into a better, more complex, or more advanced state; an instruction to mature into an improved condition; the most common starting sequence for the first 5 amino acids of human antibody heavy chains.

At EVQLV, we leverage our expertise in machine learning, computational biology, drug development, and software engineering to transform the pace, cost, and scale of antibody discovery. Our proprietary computational platform EVQLVes antibody discovery by generating diverse, fully-human antibodies.